首页>
外国专利>
Antibody that binds human delta-like ligand 4 (dll4) and chemotherapeutic agent for treating cancer
Antibody that binds human delta-like ligand 4 (dll4) and chemotherapeutic agent for treating cancer
展开▼
机译:结合人三角洲样配体4(dll4)和用于治疗癌症的化学治疗剂的抗体
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides methods for treating various types of cancer/tumor by administering the combination of Dll4 antagonists, in particular, Dll4 antibodies and fragments thereof that specifically bind human Dll4, and chemotherapeutic agents. Such combination therapies exhibit synergistic effects compared to the treatment with either agent alone. Thus, the methods of the invention are particularly beneficial for cancer patients who have low tolerance to the side effects caused by high dosages required for the treatment by either agent alone, by being able to reduce effective dosages. Pharmaceutical compositions and kits containing Dll4 antagonists and chemotherapeutic agents are also provided.
展开▼